Condensed Consolidated Statement of Profit and Loss and Other Comprehensive Loss - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 03, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Condensed Consolidated Statement of Profit and Loss and Other Comprehensive Loss | ||||||
| Revenue | $ 266,446 | $ 71,293 | $ 322,921 | $ 79,272 | $ 16,034 | |
| Clinical care delivery expense | (23,927) | (11,823) | (289,672) | (67,254) | (19,810) | |
| Claims expense | (247,552) | (23,917) | ||||
| Platform & application expenses | (16,703) | (6,434) | (42,829) | (38,137) | (23,569) | |
| Research & development expenses | (10,057) | (10,390) | (47,534) | (54,711) | (51,205) | |
| Sales, general & administrative expenses | (58,310) | (31,479) | (196,673) | (94,681) | (84,270) | |
| Recapitalization transaction expense | $ (148,700) | (148,722) | ||||
| Operating loss | (90,103) | (12,750) | (402,509) | (175,511) | (162,820) | |
| Finance costs | (6,628) | (992) | (14,291) | (4,530) | (1,116) | |
| Finance income | 255 | 14 | 326 | 610 | 1,015 | |
| Change in fair value of warrant liabilities | 5,575 | 27,811 | ||||
| Exchange loss | (447) | (573) | 868 | (2,836) | 17,075 | |
| Net finance expense | (1,245) | (1,551) | 14,714 | (6,756) | 16,974 | |
| Gain on sale of subsidiary | 3,917 | 3,917 | ||||
| Gain on remeasurement of equity interest | 10,495 | |||||
| Share of loss of equity-accounted investees | (455) | (2,602) | (1,124) | |||
| Loss before taxation | (91,348) | (10,839) | (375,985) | (183,391) | (145,846) | |
| Tax provision | (9) | (8) | 1,474 | (4,639) | 5,559 | |
| Loss for the period | (91,357) | (10,847) | (374,511) | (188,030) | (140,287) | |
| Other comprehensive loss Items that may be reclassified subsequently to profit or loss: | ||||||
| Currency translation differences | (3,753) | (1,754) | (1,702) | 3,579 | (9,693) | |
| Other comprehensive loss for the period, net of income tax | (3,753) | (1,754) | (1,702) | 3,579 | (9,693) | |
| Total comprehensive loss for the year | (95,110) | (12,601) | (376,213) | (184,451) | (149,980) | |
| Loss attributable to: | ||||||
| Equity holders of the parent | (91,357) | (10,466) | (368,482) | (186,799) | (140,287) | |
| Non-controlling interest | (381) | (6,029) | (1,231) | |||
| Loss for the period | (91,357) | (10,847) | (374,511) | (188,030) | (140,287) | |
| Total comprehensive loss attributable to: | ||||||
| Equity holders of the parent | (95,110) | (12,220) | (370,184) | (183,220) | (149,980) | |
| Non-controlling interest | (381) | (6,029) | (1,231) | |||
| Total comprehensive loss for the year | $ (95,110) | $ (12,601) | $ (376,213) | $ (184,451) | $ (149,980) | |
| Loss per share | ||||||
| Net loss per share, Basic and Diluted (in usd per share) | $ (0.24) | $ (0.04) | $ (1.36) | $ (0.77) | $ (0.58) | |
| Weighted average shares outstanding, Basic and Diluted (in shares) | 384,531,450 | 245,229,566 | 271,321,253 | 242,935,770 | 241,903,166 | |
| X | ||||||||||
- Definition Change In Fair Value Of Warrant Liabilities No definition available.
|
| X | ||||||||||
- Definition Claims Expense No definition available.
|
| X | ||||||||||
- Definition Gain (Loss) On Sale Of Subsidiary No definition available.
|
| X | ||||||||||
- Definition Gain On Remeasurement Of Equity Interest No definition available.
|
| X | ||||||||||
- Definition Platform And Application Expenses No definition available.
|
| X | ||||||||||
- Definition Recapitalization Transaction Expense No definition available.
|
| X | ||||||||||
- Definition Weighted Average Shares Outstanding, Basic And Diluted No definition available.
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of costs associated with financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income or cost associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to selling, general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|